Indian Immunologicals Limited Managing Director Dr K Anand Kumar has received the FABA Lifetime Achievement Award for his contributions to biotechnology, vaccine research and manufacturing, and efforts to strengthen India’s vaccine ecosystem and improve access to affordable human and animal healthcare.
Anger is rising over India’s drug regulators for failing to issue a public advisory on counterfeit Abhayrab rabies vaccines. Despite alerts from Indian Immunologicals Limited, authorities chose a quiet probe, prompting ethical concerns after global warnings were issued by foreign regulators.
India’s first indigenous malaria vaccine, AdFalci Vax, is set to be produced in Hyderabad after ICMR licensed Indian Immunologicals and Biological E. The multi-stage recombinant vaccine targets malaria at different stages, has shown strong pre-clinical results, and requires only one shot
This brand-new unit will have a BSL3 facility for the manufacture of drug substances and a fill-finish capability for the production of both drug products FMD vaccine and the FMD HS vaccine.
The MR vaccine of Indian Immunologicals is the outcome of Indo-Vietnam partnership, wherein IIL has partnered with Center for Research and Production of Vaccines and Biologicals, also called Polyvac in Vietnam
Hyderabad-based Indian Immunologicals Limited announced a strategic partnership with CIFE, Mumbai, an Indian Council of Agricultural Research Institute
This is part of efforts to meet the vaccine security of the nation against economically important diseases such as foot-and-mouth disease (FMD) and other emerging diseases.
